ALK-Abelló A/S (OTC:AKBLF) Shares Up 1.4% – What’s Next?

ALK-Abelló A/S (OTC:AKBLFGet Free Report) was up 1.4% during trading on Friday . The company traded as high as $22.35 and last traded at $22.35. Approximately 100 shares changed hands during mid-day trading, a decline of 82% from the average daily volume of 559 shares. The stock had previously closed at $22.05.

ALK-Abelló A/S Trading Up 1.4 %

The firm has a fifty day simple moving average of $23.24 and a 200 day simple moving average of $22.86.

About ALK-Abelló A/S

(Get Free Report)

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.

Featured Articles

Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.